Paclitaxel
- Product NDC
- 70860-215
- 11-digit product format
- 708600215
- Labeler code
- 70860
- Product ID
- 70860-215_5e0b1e04-b721-439a-977c-b10a21fedc78
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- paclitaxel
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS
- Labeler
- Athenex Pharmaceutical Division, LLC.
- Application
- ANDA207326
- Marketing category
- ANDA
- Marketing start
- 2019-11-30
- Marketing end
- 0000-00-00
- Substance
- PACLITAXEL
- Active strength
- 6 mg/mL
- Pharmacologic classes
- Microtubule Inhibition [PE],Microtubule Inhibitor [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70860-215-66 | 70860021566 | 1 VIAL in 1 CARTON (70860-215-66) > 5 mL in 1 VIAL | 1 vial | 2021-12-15 | 0000-00-00 | No | No | Current |
| 70860-215-67 | 70860021567 | 1 VIAL in 1 CARTON (70860-215-67) > 16.7 mL in 1 VIAL | 1 vial | 2021-12-15 | 0000-00-00 | No | No | Current |
| 70860-215-68 | 70860021568 | 1 VIAL in 1 CARTON (70860-215-68) > 50 mL in 1 VIAL | 1 vial | 2019-11-30 | 0000-00-00 | No | No | Current |